Glisson BS - Search Results

1

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.

Kim ES, Lu C, Khuri FR, Tonda M, Glisson BS, Liu D, Jung M, Hong WK, Herbst RS. Kim ES, et al. Among authors: glisson bs. Lung Cancer. 2001 Dec;34(3):427-32. doi: 10.1016/s0169-5002(01)00278-1. Lung Cancer. 2001. PMID: 11714540 Clinical Trial.

2

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: glisson bs. J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039. J Natl Cancer Inst. 1992. PMID: 1318977 Clinical Trial. No abstract available.

3

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: glisson bs. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

4

Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).

Zatopek NK, Holoye PY, Ellerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang AC, Glisson BS. Zatopek NK, et al. Among authors: glisson bs. Am J Clin Oncol. 1991 Oct;14(5):427-32. doi: 10.1097/00000421-199110000-00013. Am J Clin Oncol. 1991. PMID: 1659177

5

Ifosfamide with mesna uroprotection in the management of lung cancer.

Holoye PY, Glisson BS, Lee JS, Dhingra HM, Murphy WK, Umsawasdi T, Levy JK, Jeffries D, Raber MN, Hong WK. Holoye PY, et al. Among authors: glisson bs. Am J Clin Oncol. 1990 Apr;13(2):148-55. doi: 10.1097/00000421-199004000-00012. Am J Clin Oncol. 1990. PMID: 2156418

6

The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission.

Holoye PY, McMurtrey MJ, Mountain CF, Murphy WK, Dhingra HM, Umsawasdi T, Glisson BS, Lee JS, Carr DT, Valdivieso M, et al. Holoye PY, et al. Among authors: glisson bs. J Clin Oncol. 1990 Mar;8(3):416-22. doi: 10.1200/JCO.1990.8.3.416. J Clin Oncol. 1990. PMID: 2307986

7

Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.

Kim HK, Zwelling LA, Sacks PG, Hong WK, Chan D, Silberman L, Glisson BS. Kim HK, et al. Among authors: glisson bs. Cancer Res. 1989 Mar 1;49(5):1197-201. Cancer Res. 1989. PMID: 2537145

8

Primary chemotherapy of brain metastasis in small-cell lung cancer.

Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK. Lee JS, et al. Among authors: glisson bs. J Clin Oncol. 1989 Jul;7(7):916-22. doi: 10.1200/JCO.1989.7.7.916. J Clin Oncol. 1989. PMID: 2544685 Clinical Trial.

9

Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma.

Holoye PY, Carr DT, Dhingra HM, Glisson BS, Lee JS, Murphy WK, Umsawasdi T, Jeffries D. Holoye PY, et al. Among authors: glisson bs. Invest New Drugs. 1988 Sep;6(3):217-8. doi: 10.1007/BF00175401. Invest New Drugs. 1988. PMID: 2847992

10

Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.

Komaki R, Shin DM, Glisson BS, Fossella FV, Murphy WK, Garden AS, Oswald MJ, Hong WK, Roth JA, Peters LJ, et al. Komaki R, et al. Among authors: glisson bs. Int J Radiat Oncol Biol Phys. 1995 Feb 15;31(4):807-11. doi: 10.1016/0360-3016(94)00463-3. Int J Radiat Oncol Biol Phys. 1995. PMID: 7860392 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page